✦ LIBER ✦
Shorter survival-times following adjuvant endocrine therapy in oestrogen- and progesterone-receptor positive breast cancer overexpressing HER2 and/or with an increased expression of vascular endothelial growth factor
✍ Scribed by B. Linderholm; J. Bergqvist; H. Hellborg; U. Johansson; M. Linderholm; E. von Schoultz; G. Elmberger; L. Skoog; J. Bergh
- Publisher
- Springer US
- Year
- 2009
- Tongue
- English
- Weight
- 455 KB
- Volume
- 26
- Category
- Article
- ISSN
- 1357-0560
No coin nor oath required. For personal study only.